Statins, Diabetic Oxidative Stress and Vascular Tissue

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter summarizes the basic and clinical science supporting the role of oxidative stress pathways in linking hyperglycemia to diabetic vascular disease. In addition to exploring the etiology and consequences of various sources of oxidative stress in diabetes, this chapter will focus on hydroxymethyl-glutaryl coA reductase inhibitors (or 'statins') for their impact on oxidative stress in diabetes - especially in their effects independent of lowering plasma lipids. The interaction of statins on tissue oxidases and on nitric oxide synthase uncoupling will be considered. Finally, this chapter addresses the key clinical trials of statins that have been shown to influence the development or progression of diabetic vascular disease.

Original languageEnglish (US)
Title of host publicationDiabetes
Subtitle of host publicationOxidative Stress and Dietary Antioxidants
PublisherElsevier Inc.
Pages183-190
Number of pages8
ISBN (Print)9780124058859
DOIs
StatePublished - Nov 1 2013

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Blood Vessels
Diabetic Angiopathies
Oxidative Stress
Oxidoreductases
Nitric Oxide Synthase
Hyperglycemia
Clinical Trials
Lipids

Keywords

  • Hyperlipidemia
  • Nitric oxide
  • Oxidative stress
  • Statin
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

Cite this

Murrow, J. R. (2013). Statins, Diabetic Oxidative Stress and Vascular Tissue. In Diabetes: Oxidative Stress and Dietary Antioxidants (pp. 183-190). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-405885-9.00019-X

Statins, Diabetic Oxidative Stress and Vascular Tissue. / Murrow, Jonathan R.

Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc., 2013. p. 183-190.

Research output: Chapter in Book/Report/Conference proceedingChapter

Murrow, JR 2013, Statins, Diabetic Oxidative Stress and Vascular Tissue. in Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc., pp. 183-190. https://doi.org/10.1016/B978-0-12-405885-9.00019-X
Murrow JR. Statins, Diabetic Oxidative Stress and Vascular Tissue. In Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc. 2013. p. 183-190 https://doi.org/10.1016/B978-0-12-405885-9.00019-X
Murrow, Jonathan R. / Statins, Diabetic Oxidative Stress and Vascular Tissue. Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc., 2013. pp. 183-190
@inbook{03d28290c17e4cb6b9880130e359bb5b,
title = "Statins, Diabetic Oxidative Stress and Vascular Tissue",
abstract = "This chapter summarizes the basic and clinical science supporting the role of oxidative stress pathways in linking hyperglycemia to diabetic vascular disease. In addition to exploring the etiology and consequences of various sources of oxidative stress in diabetes, this chapter will focus on hydroxymethyl-glutaryl coA reductase inhibitors (or 'statins') for their impact on oxidative stress in diabetes - especially in their effects independent of lowering plasma lipids. The interaction of statins on tissue oxidases and on nitric oxide synthase uncoupling will be considered. Finally, this chapter addresses the key clinical trials of statins that have been shown to influence the development or progression of diabetic vascular disease.",
keywords = "Hyperlipidemia, Nitric oxide, Oxidative stress, Statin, Type 2 diabetes mellitus",
author = "Murrow, {Jonathan R}",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/B978-0-12-405885-9.00019-X",
language = "English (US)",
isbn = "9780124058859",
pages = "183--190",
booktitle = "Diabetes",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Statins, Diabetic Oxidative Stress and Vascular Tissue

AU - Murrow, Jonathan R

PY - 2013/11/1

Y1 - 2013/11/1

N2 - This chapter summarizes the basic and clinical science supporting the role of oxidative stress pathways in linking hyperglycemia to diabetic vascular disease. In addition to exploring the etiology and consequences of various sources of oxidative stress in diabetes, this chapter will focus on hydroxymethyl-glutaryl coA reductase inhibitors (or 'statins') for their impact on oxidative stress in diabetes - especially in their effects independent of lowering plasma lipids. The interaction of statins on tissue oxidases and on nitric oxide synthase uncoupling will be considered. Finally, this chapter addresses the key clinical trials of statins that have been shown to influence the development or progression of diabetic vascular disease.

AB - This chapter summarizes the basic and clinical science supporting the role of oxidative stress pathways in linking hyperglycemia to diabetic vascular disease. In addition to exploring the etiology and consequences of various sources of oxidative stress in diabetes, this chapter will focus on hydroxymethyl-glutaryl coA reductase inhibitors (or 'statins') for their impact on oxidative stress in diabetes - especially in their effects independent of lowering plasma lipids. The interaction of statins on tissue oxidases and on nitric oxide synthase uncoupling will be considered. Finally, this chapter addresses the key clinical trials of statins that have been shown to influence the development or progression of diabetic vascular disease.

KW - Hyperlipidemia

KW - Nitric oxide

KW - Oxidative stress

KW - Statin

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=84902231716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902231716&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-405885-9.00019-X

DO - 10.1016/B978-0-12-405885-9.00019-X

M3 - Chapter

AN - SCOPUS:84902231716

SN - 9780124058859

SP - 183

EP - 190

BT - Diabetes

PB - Elsevier Inc.

ER -